Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2551 0.2748%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Covidien PLC

Add to Portfolio

COV:US

53.3200 USD 0.1400 0.26%

As of 20:04:07 ET on 05/25/2012.

Snapshot for Covidien PLC (COV)

Open: 53.5400 Day's Range: 53.1400 - 53.8100 Volume: 1,858,094 Bid: 53.3200
Previous Close: 53.4600 52wk Range: 41.3500 - 56.2000 1-Yr Rtn: -0.50% Ask: 53.3300

Stock Chart for COV

No chart data available.
  • COV:US 53.3200
  • 1D
  • 1M
  • 1Y
53.4600
Interactive COV Chart

Previous Close

Key Statistics for COV

Current P/E Ratio (ttm) 12.2857
Estimated P/E (09/2012) 12.4000
Earnings Per Share (USD) (ttm) 4.3400
Est. EPS (USD) (09/2012) 4.3000
Est. PEG Ratio 1.0850
Market Cap (M USD) 25,715.07
Shares Outstanding (M) 482.28
Enterprise Value (M USD) (ttm) 28,387.07
Enterprise Value/EBITDA (ttm) 8.94
Price/Book (mrq) 2.4410
Price/Sale (ttm) 2.1926
Dividend Indicated Gross Yield 1.6879
Next Earnings Announcement 07/26/2012
More COV Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for COV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More COV Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More COV Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More COV Cash Flow Data

Company Profile & Key Executives for COV

Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Jose E Almeida "Joe"Chairman/President/CEOJohn H MastersonSenior VP/General Counsel
Kevin G DasilvaVP/CFOGregory S Andrulonis "Greg"VP/Treasurer
More Company Profile & Key Executives for COV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements